FAQs

Frequently Asked Questions

What is the 7th Gene Therapy Analytical Development Summit Europe?

The Gene Therapy Analytical Development Summit Europe is Europe’s leading meeting dedicated to analytical development, potency assurance, QC strategy, and regulatory readiness for gene therapies.

The summit brings together analytical scientists, QC leaders, CMC experts, and regulators who are defining how potency, quality, safety, and consistency are measured across viral and non-viral gene therapy modalities.

Taking place in London, this specialist forum provides a highly technical, peer-level environment to address the analytical challenges that directly impact clinical progression and late-stage success.

Who Should Attend the Summit?

The summit is designed for professionals responsible for analytical strategy, assay performance, and regulatory alignment across gene therapy programmes.

Attendees typically include:

Senior Analytical Development Scientists & Technical Leads
QC & GMP Release Scientists
Potency Assay Developers & Bioassay Experts
CMC, MSAT & Tech Transfer Professionals
Regulatory Affairs & CMC Strategy Leads
Senior Viral Vector & Non-Viral Platform Scientists

This is a must-attend meeting for teams translating complex analytical data into confident development and regulatory decisions.

What Topics Will Be Covered?

The 2026 agenda addresses the most pressing analytical challenges facing gene therapy developers, including:

Potency assay design, variability reduction, and assurance strategies
Phase-appropriate qualification versus validation
Designing assays that survive tech transfer, scale-up, and PPQ
Impurity profiling and safety considerations
Universal reference materials, standardisation efforts, and regulatory alignment

Find out more in the agenda.

What Makes This Summit Different from Broader Gene Therapy Conferences?

Unlike broader gene therapy, manufacturing, or clinical meetings, this summit is exclusively focused on analytics.

Rather than covering vector design or clinical results at a high level, the programme dives into:

How assays are built and why they fail
How results are interpreted
What regulators expect
How analytical decisions affect timelines and risk

This depth enables more technical discussions, relevant networking, and greater practical value for analytical and QC teams compared with general gene therapy or bioprocessing conferences.

Are There Any Discounts Available?

How Can I Contact the Gene Therapy Analytical Development EU Team?

Explore the Agenda

Preview regulator-led discussions on analytical strategy, alongside hands-on workshops exploring real-world approaches to assay challenges, QC readiness, and potency assurance.

View Presentations & Speakers

Partner With Us

Position yourself as the go-to solution provider by showcasing your expertise and value to a room full of biopharma KOLs.

Explore Sponsorship Options

Join Biopharma Experts

Engage with analytical development, QC, CMC, and regulatory leaders through structured networking, roundtables, and small-group discussions to accelerate your gene therapy pipelines.

Frequently Asked Questions

Explore the Agenda

Partner With Us

Join Biopharma Experts

Venue

Map

Contact

Join Our Team

About Us

Explore Our Products

Stay Connected

Search

Organized By